Smart Inhalers Market

Global Smart Inhalers Market: Global Size, Trends, Competitive, And Historical & Forecast Analysis, 2022-2029: Increasing prevalence of asthma and chronic respiratory diseases across the globe and technological advancements are some of the major factors driving the growth of the Global Smart Inhalers Market.

Global Smart Inhalers Market is valued at USD 115.52 Million in 2022 and is expected to reach USD 713.96 Million by 2029 with a CAGR of 22.43% over the forecast period.

Scope-

Smart inhalers are devices that use the breath to deliver a variety of inhalers containing glucocorticoids and contain glucocorticoids, medications. Betaagonists, anticholinergics, and insulin and are used to treat and prevent respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). These inhalers are known as smart inhalers since sensors are attached to the inhalers as a clip to monitor the right dose per usage and the methods used to inhale the medication. The sensor's data is shared with the patient and healthcare professionals to track their usage of inhalers. The monitored information is then communicated via Bluetooth to their smartphone platforms via an online platform, resulting in the creation of electronic health records (EHR) or electronic medical records (EMR).

Some smart inhalers have sensors that can detect whether an individual is in a polluted or pollen-filled environment, send helpful reminders, and indicate if an inhaler technique should be reviewed. Individuals are not required to maintain their own records as they are all intended to track how commonly an inhaler is used instantly.

Despite the fact that the COVID-19 pandemic has interrupted numerous healthcare activities, the smart inhalers market continues to grow at a rapid pace. The rising prevalence of various respiratory complications among COVID-19 patient populations has increased market demand. Furthermore, a sharp rise in patient visits and hospitalizations related to chronic diseases and breathing problems increased the requirement for effective respiratory care, enhancing market demand. Furthermore, the growing number of COVID-19 individuals suffering side effects like COPD has resulted in a significant disease burden.

The global Smart Inhalers market is segmented based on the product, disease indication, distribution channel, and region & country level. Based on product, the global Smart Inhalers market is segmented into Dry powder inhalers (DPI)-based smart inhalers and Metered dose inhaler (MDI)-based smart inhalers. By disease indication, the market is segmented into Asthma and chronic obstructive pulmonary diseases. By distribution channel, the global Smart Inhalers market is segmented into Hospital pharmacies, Retail pharmacies, and E-commerce.

The regions covered in the global Smart Inhalers market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global Smart Inhalers is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.

Key Players-

Some major key players for the global Smart Inhalers market report cover prominent players like -

• 3M
• Adherium Limited
• AstraZeneca plc
• Boehringer Ingelheim
• Chiesi Group
• Cipla
• GlaxoSmithKline plc
• H&T Presspart
• Keller Medical
• Novartis AG
• Novus Capital Limited
• Opko Health
• Sensirion AG
• Teva Pharmaceutical Industries
• Vectura Group
• Others

Segmentation-

By Type of Inhaler

• Dry Powder Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)

By Technology

• Bluetooth-enabled inhalers
• Inhalers with sensors
• App-connected inhalers

By Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By End-User

• Hospitals
• Patients
• Pharmacies

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Increasing prevalence of asthma across the globe, increasing prevalence of chronic respiratory diseases, and technological advancements are some of the major factors driving the growth of the Global Smart Inhalers Market

The market for smart inhalation devices is seeing significant development potential due to the rising prevalence of acute respiratory disorders including COPD and asthma throughout the world. Chronic obstructive pulmonary disease (COPD), which claimed 3.23 million lives in 2019, is the third most common cause of death globally, according to the World Health Organization. In low- and middle-income nations, COPD fatalities in people under 70 years of age account for about 90% of all mortality (LMIC).

Additionally, a number of risk factors, including prolonged tobacco use, indoor air pollution, hazardous gases and particles, and occupational dust, influence the development of COPD and necessitate ongoing care management. Therefore, segmental demand is expected to be driven during the expected period by the rising prevalence rate of COPD and the increasing necessity for efficient treatment.

One of the key drivers of the revenue growth is the rising prevalence of a number of chronic respiratory disorders, including COPD and asthma, worldwide. For instance, according to the World Health Organization, asthma affected almost 262 million people worldwide and is the most frequent chronic condition affecting children.

Additionally, it is projected that the COVID-19 pandemic would benefit the market for smart inhalers. To expand hospital capacity for patients with COVID-19 diagnoses, a sizable number of clinics and hospitals throughout the world underwent restructuring. The fast increase in COVID-19 cases resulted in a possible backlog for non-essential procedures. The lockout caused delays in the production and delivery of critical medical supplies. The rise in chronic respiratory illness cases resulted in a considerable increase in hospital and clinic visits, which in turn raised the demand for inhalers and nebulizers and drove market expansion.

With the use of Bluetooth, digital inhalers can be connected to smartphones, providing dosing remaining and dosage monitoring procedures. Additionally, these devices include patient education tools that reduce dosage action mistakes, which lowers hospitalization and treatment costs. Major corporations are working together to provide more cutting-edge products. For example, in February 2022 Honeywell announced a business agreement with AstraZeneca to create and sell next-generation inhalers that employ propellants with almost 0% global warming potential (GWP) to treat COPD and asthma.

The potential of data leakage and misuse greatly rises with the wireless connectivity of smart inhalers and their ability to capture the patient's data. Since the smart inhaler is a relatively new invention, both patients' and doctors' acceptance of it is very low, which is predicted to limit market expansion.

North America is Expected to Capture a Major Share in the Global Smart Inhalers Market

The affordability of smart inhalers among the target population and ongoing technological developments in the field of respiratory illness management are expected to influence the prognosis for the regional market for smart inhalers. Forecasts for the North American market will also be boosted by the region's high healthcare spending and rising disposable income. Additionally, the substantial presence of well-established market participants and the favorable regulatory environment result in a number of product launches and approvals in the region, particularly in the United States. Increasing the market size in North America as a result.

As more vendors enter the untapped rising Asian nations, the market in the Asia Pacific region is expected to expand at a significant rate. Additionally, rising expenditures for healthcare IT development in emerging nations is expected to further boost regional growth.

News-

Aptar Pharma Introduced the HeroTracker Sense, a Novel Attached Smart Device for Respiratory Disease.

On February 8, 2022; Aptar Pharma, a world leader in drug delivery services, systems, and active materials research solutions, launched HeroTracker Sense, a unique digital lung health solution that converts a regular metered dosage inhaler (pMDI) into a smart linked healthcare device. HeroTracker Sense is a metered-dose inhaler (MDI) add-on linked device that addresses patient inhalation method and adherence.

Aptar Pharma has acquired the rights to the Orbital dry power inhaler.

On August 8, 2022; The Orbital inhaler from clinical stage drug development Pharmaxis, a device that delivers high payload powder to the lungs, was purchased by Aptar Pharma, a supplier of drug delivery and active materials research solutions, for use globally.

Healthcare Sector Cybersecurity Matrix Launched by HSCC

On September 27, 2019; The US Healthcare and Public Health Industry Coordinating Council developed HSCC as an online resource to enhance cyber security in the healthcare sector (HSCC). The resource's goal is to aggregate sources that offer cybersecurity info.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2022:	USD 115.52 Million
Base year considered	2021
Forecast Period CAGR %:	22.43%
Market Size Expected in 2029:	USD 713.96 Million
Tables, Charts & Figures:	175
Pages	300
Manufacturers	3M, Adherium Limited, AstraZeneca plc, Boehringer Ingelheim, Chiesi Group, Cipla, GlaxoSmithKline plc, H&T Presspart, Keller Medical, Novartis AG, Novus Capital Limited, Opko Health, Sensirion AG, Teva Pharmaceutical Industries, Vectura Group, Others.
Segments Covered	By Product, By Disease Indication, By Distribution Channel
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa